Asian Tribune Your Multilingual Newspaper covering World and local news News
Pharma company Zydus Cadila today received restricted Emergency use approval from India’s drug regulator for the use of Virafin, Pegylated Interferon alpha-2b (PegIFN) in treating moderate Covid-19 infection in adults. When administered early on during Covid, Virafin will help patients recover faster and avoid much of the complications, the company …
Read More »Zydus gets emergency nod for Pegylated Interferon alpha-2b, ‘Virafin’ for Covid-19 treatment in adults, Health News, ET HealthWorld
